- $1.03tn
- $1.07tn
- $65.18bn
Brief: Camurus Announces Expansion Of Lilly Collaboration
Unit of China's Haisco, Eli Lilly sign collaboration, licensing deals
Brief: Haisco Pharmaceutical Signs Licensing, R&D Collaboration Agreement With Eli Lilly
Brief: Hanmi Pharm Co Enters License Agreement With Eli Lilly For Sonefpeglutide
Health Rounds: Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's
U.S. STOCKS ON THE MOVE-Dave, Quanta Services, Union Pacific Corp
Eli Lilly rises after CVS reinstates Zepbound coverage
U.S. STOCKS ON THE MOVE-Dollar Tree, Kohl's, Oil companies
U.S. STOCKS ON THE MOVE-Snowflake, Nebius Group, Eli Lilly
CVS brings back coverage for Lilly's obesity drug Zepbound (updated)
Eli Lilly rises after CVS reinstates Zepbound coverage
CVS brings back coverage for Lilly's obesity drug Zepbound
Brief: CVS Says CVS Caremark To Add Zepbound To Commercial Formularies As Additional Preferred Option On Oct 1
France becomes first EU country to reimburse anti-obesity drugs, minister says (updated)
France to reimburse weight-loss drugs from mid-June, health minister says
New York Times business news - May 27
Press Digest: Wall Street Journal - May 27
Deals of the day-Mergers and acquisitions